MOLN:SWX
Molecular Partners AG
CHF 3.08
arrow_upward
+0.65%(+0.020) 1D
Oct 20, 10:07:20 AM GMT+2 · CHF
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLN...
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.08
Mkt. cap
124.35M
Avg. vol.
10.48K
Volume
533.00
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
Open
CHF 3.08
High
CHF 3.10
Low
CHF 3.08
Mkt. cap
124.35M
Avg. vol.
10.48K
Volume
533.00
52-wk high
CHF 3.96
52-wk low
CHF 2.66
EPS
-CHF 1.37
Shares outstanding
40.37M
No. of employees
134
News stories
From web sources and news partners
FXLeaders
·
21 minutes ago
Dow Futures Gain Short-Term Momentum Clashes With US Treasury Yields
FXStreet
·
1 hour ago
S&P 500: Tech rebound offsets broader weakness – Deutsche Bank
The Motley Fool
·
27 minutes ago
IVV vs. SPY: Which S&P 500 ETF Is the Better Buy for Long-Term Investors?
Yahoo Finance
·
1 hour ago
Should You Wait Until After the Midterm Elections to Buy the S&P 500?
Profile
Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. Wikipedia
About Molecular Partners AG